Abstract
Rheumatoid arthritis (RA) is a common systemic inflammatory autoimmune disease characterized by painful, swollen joints that can severely impair physical function and quality of life. The presenting symptoms of musculoskeletal pain, swelling, and stiffness are common in clinical practice, so familiarity with diagnosing and managing RA is crucial. Patients with RA are at greater risk for serious infection, respiratory disease, osteoporosis, cardiovascular disease, cancer, and mortality than the general population. In recent years, early diagnosis, aggressive treatment, and expanded therapeutic options of disease-modifying antirheumatic drugs have markedly improved both the management and long-term prognosis of RA.
MeSH terms
-
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
-
Antirheumatic Agents / adverse effects
-
Antirheumatic Agents / therapeutic use
-
Arthritis, Rheumatoid / classification
-
Arthritis, Rheumatoid / complications
-
Arthritis, Rheumatoid / diagnosis*
-
Arthritis, Rheumatoid / drug therapy*
-
Biosimilar Pharmaceuticals / therapeutic use
-
Complementary Therapies
-
Diagnosis, Differential
-
Diet
-
Glucocorticoids / administration & dosage
-
Glucocorticoids / therapeutic use
-
Humans
-
Occupational Therapy
-
Patient Care Team
-
Patient Education as Topic
-
Physical Examination
-
Physical Therapy Modalities
-
Referral and Consultation
-
Risk Factors
Substances
-
Anti-Inflammatory Agents, Non-Steroidal
-
Antirheumatic Agents
-
Biosimilar Pharmaceuticals
-
Glucocorticoids